Open AccessSilymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression
Author(s) -
M. Y. Permana,
Tjahjani Mirawati Soediro,
Melva Louisa
Publication year - 2018
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/1073/3/032055
Subject(s) - doxorubicin , mcf 7 , abcg2 , breast cancer , cancer cell , pharmacology , efflux , viability assay , cancer research , cancer , medicine , cytotoxicity , chemistry , chemotherapy , apoptosis , in vitro , transporter , human breast , atp binding cassette transporter , biochemistry , gene